Monaco Ashley, Sommer Jessica, Akerman Meredith, Joshi Parth, Corcoran Anthony, Katz Aaron
New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, USA.
Department of Urology, New York University Langone, Hospital-Long Island, Mineola, New York, USA.
J Endourol. 2022 Dec;36(12):1625-1631. doi: 10.1089/end.2022.0068. Epub 2022 Oct 7.
The purpose of this study is to analyze quality-of-life (QoL) metrics in men treated with focal cryoablation (FC) compared with active surveillance (AS) for localized prostate cancer over a 4-year follow-up period. We further investigated the effect of prostate size and minimum tumor temperature on QoL outcomes. An Institutional Review Board-approved database was reviewed for patients who underwent FC or AS. QoL questionnaire responses were collected and scores were analyzed for differences between FC and AS, between prostate volume <50 cc and ≥50 cc, and "cold" (<-78°C) and "warm" (≥-78°C) tumor temperatures. One hundred forty-eight AS and 60 FC patients were included. Compared with AS, no significant difference existed in urinary function (UF) measured by Expanded Prostate Cancer Index Composite (EPIC) ( = 0.593) and International Prostate Symptom Score (IPSS) ( = 0.241), bowel habits ( = 0.370), or anxiety ( = 0.672) across time post-FC. FC had significantly worse sexual function (SF) compared with AS measured by EPIC ( < 0.0001) and International Index of Erectile Function (IIEF) ( < 0.0001). Patients with prostate volume <50 cc did not demonstrate differences between AS and FC in UF on EPIC ( = 0.459) or IPSS ( = 0.628), but FC patients had worse SF on EPIC ( < 0.001) and IIEF ( < 0.001). FC patients with a prostate volume ≥50 cc had better UF measured by IPSS ( < 0.05) and similar SF on EPIC ( = 0.162) and IIEF ( = 0.771) compared with AS. UF over time measured by EPIC (0.825) and IPSS ( = 0.658) was the same between AS, "warm," and "cold" FC groups. AS had significantly better SF than the "warm" and "cold" FC groups on EPIC ( < 0.001) and IIEF ( < 0.05). No differences were found in anxiety, urinary, or bowel function between AS and FC. Despite differences in SF, patients with larger prostates had no difference in SF and improved UF compared with AS. Future studies with larger cohorts are needed.
本研究的目的是分析在4年随访期内,接受聚焦冷冻消融术(FC)与主动监测(AS)治疗局限性前列腺癌的男性的生活质量(QoL)指标。我们进一步研究了前列腺大小和最低肿瘤温度对生活质量结果的影响。对机构审查委员会批准的数据库中接受FC或AS治疗的患者进行了回顾。收集了生活质量问卷的回复,并分析了FC和AS之间、前列腺体积<50 cc和≥50 cc之间以及“冷”(<-78°C)和“暖”(≥-78°C)肿瘤温度之间的得分差异。纳入了148例AS患者和60例FC患者。与AS相比,在FC术后各时间点,通过扩展前列腺癌指数综合评分(EPIC)(P = 0.593)和国际前列腺症状评分(IPSS)(P = 0.241)测量的排尿功能(UF)、排便习惯(P = 0.370)或焦虑(P = 0.672)均无显著差异。与AS相比,通过EPIC(P < 0.0001)和国际勃起功能指数(IIEF)(P < 0.0001)测量,FC的性功能(SF)明显更差。前列腺体积<50 cc的患者在EPIC(P = 0.459)或IPSS(P = 0.628)的UF方面,AS和FC之间没有差异,但FC患者在EPIC(P < 0.001)和IIEF(P < 0.001)上的SF更差。与AS相比,前列腺体积≥50 cc的FC患者通过IPSS测量的UF更好(P < 0.05),在EPIC(P = 0.162)和IIEF(P = 0.771)上的SF相似。通过EPIC(P = 0.825)和IPSS(P = 0.658)测量的AS组、“暖性”和“冷性”FC组随时间的UF相同。在EPIC(P < 0.001)和IIEF(P < 0.05)上,AS的SF明显优于“暖性”和“冷性”FC组。在焦虑、排尿或排便功能方面,AS和FC之间没有差异。尽管性功能存在差异,但前列腺较大的患者与AS相比,性功能没有差异,排尿功能有所改善。需要对更大队列进行未来研究。